Hematology & Oncology
What they do most for Medicare patients
| Service, sort | Times billed, sort |
|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 2,985,577 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 2,261,618 |
| Insertion of needle into vein for collection of blood sample | 1,944,424 |
| Blood test, comprehensive group of blood chemicals | 1,201,440 |
| Established patient office or other outpatient visit, 20-29 minutes | 1,187,591 |
| Established patient office or other outpatient visit, 40-54 minutes | 1,117,544 |
| Administration of chemotherapy into vein, 1 hour or less | 716,225 |
| Injection of drug or substance under skin or into muscle | 714,845 |
| Injection of additional new drug or substance into vein | 692,512 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 566,659 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 435,439 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 414,786 |
| Flow cytometry technique for dna or cell analysis, each additional marker | 383,850 |
| Lactate dehydrogenase (enzyme) level | 362,754 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 355,600 |
| Ferritin (blood protein) level | 318,043 |
| Iron level | 278,506 |
| Gammaglobulin (immune system protein) measurement | 264,657 |
| Iron binding capacity | 256,741 |
| New patient office or other outpatient visit, 60-74 minutes | 219,217 |
| Administration of chemotherapy into vein, each additional hour | 218,868 |
| Magnesium level | 203,233 |
| Administration of additional new drug or substance into vein, 1 hour or less | 195,760 |
| Unclassified drugs | 187,520 |
| Infusion into a vein for hydration, each additional hour | 166,911 |
| New patient office or other outpatient visit, 45-59 minutes | 160,748 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 160,113 |
| Uric acid level, blood | 156,300 |
| Phosphate level | 147,759 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 144,725 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 144,663 |
| Cyanocobalamin (vitamin b-12) level | 119,464 |
| Carcinoembryonic antigen (cea) protein level | 110,127 |
| Blood test, thyroid stimulating hormone (tsh) | 99,906 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 87,036 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 86,398 |
| Folic acid level, serum | 84,793 |
| Blood test, basic group of blood chemicals (calcium, total) | 83,124 |
| Infusion into a vein for hydration, 31-60 minutes | 78,626 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test | 77,586 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 70,594 |
| Liver function blood test panel | 66,892 |
| Measurement of immunoglobulin light chains | 64,434 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 63,505 |
| Irrigation of implanted venous access drug delivery device | 60,450 |
| Psa (prostate specific antigen) measurement, total | 57,630 |
| Microscopic examination for white blood cells with manual cell count | 56,428 |
| Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | 51,138 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | 50,500 |
| Protein measurement, serum | 48,341 |
| Established patient office or other outpatient visit, 10-19 minutes | 47,887 |
| Administration of additional new drug or substance into vein using push technique | 47,300 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 44,461 |
| Lutetium lu 177 vipivotide tetraxetan, therapeutic, 1 millicurie | 42,515 |
| Injection of drug or substance into vein | 40,142 |
| Immunologic analysis technique on serum (immunofixation) | 38,894 |
| Ct scan of chest with contrast | 37,846 |
| Thyroxine (thyroid chemical), free | 37,468 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 33,561 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 32,623 |
| Vitamin d-3 level | 32,600 |
| Blood test, clotting time | 32,096 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 31,474 |
| Nephelometry, test method using light | 31,452 |
| Bilirubin level, direct | 29,621 |
| Ct scan of abdomen and pelvis with contrast | 29,532 |
| Beta-2 microglobulin (protein) level | 29,415 |
| Blood creatinine level | 29,407 |
| Collection of blood sample from implanted device | 29,250 |
| Calcium level, total | 28,699 |
| Telephone medical discussion with physician, 11-20 minutes | 27,880 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 27,179 |
| Blood chloride level | 26,948 |
| Blood sodium level | 26,388 |
| Telephone medical discussion with physician, 21-30 minutes | 26,311 |
| New patient office or other outpatient visit, 30-44 minutes | 25,468 |
| Drawing of blood for a medical problem | 25,461 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 24,440 |
| Red blood count, automated test | 23,147 |
| Measurement of substance using immunoassay technique | 21,309 |
| Bilirubin level, total | 20,833 |
| Total protein level, blood | 20,338 |
| Liver enzyme (sgot), level | 19,888 |
| Phosphatase (enzyme) level, alkaline | 19,850 |
| Liver enzyme (sgpt), level | 19,439 |
| Urea nitrogen level to assess kidney function, quantitative | 19,373 |
| Reticulated (young) platelet measurement | 19,262 |
| Albumin (protein) level | 18,946 |
| Red blood count automated, with additional calculations | 18,866 |
| Red blood count, manual test | 17,909 |
| Blood potassium level | 17,249 |
| Flow cytometry technique for dna or cell analysis, first marker | 16,414 |
| Urinalysis, manual test | 15,451 |
| Telephone medical discussion with physician, 5-10 minutes | 14,905 |
| Red blood cell sedimentation rate, to detect inflammation, non-automated | 14,146 |
| Transferrin (iron binding protein) level | 13,803 |
| Blood test, basic group of blood chemicals (calcium, ionized) | 12,814 |
| Cortisol (hormone) measurement, total | 12,631 |
| Hospital discharge day management, more than 30 minutes | 12,536 |
| Administration of influenza virus vaccine | 12,476 |
← Back to Hematology & Oncology
Sources: Medicare Care Compare (hospitals and schools; Medicare-enrolled clinicians), CMS Medicare Physician & Other Practitioners 2023 (services), Medicare Part D Prescribers 2024 (drugs).